A young Peninsula drugmaker won regulatory approval Friday for a rare-disease drug picked up in a deal two years ago.
The Chicagoland entrepreneurs seek to make everyday items more accessible for America’s growing Muslim population.
The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Church & Dwight Co., the manufacturer of Zicam products, has agreed to settle a $6 million class action suit filed in 2022 ...